Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Free Cash Flow: 2021-2025

Historic Free Cash Flow for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to -$15.4 million.

  • P3 Health Partners' Free Cash Flow rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.7 million, marking a year-over-year decrease of 7904.92%. This contributed to the annual value of -$110.1 million for FY2024, which is 4145.27% down from last year.
  • P3 Health Partners' Free Cash Flow amounted to -$15.4 million in Q3 2025, which was up 3185.96% from -$16.6 million recorded in Q2 2025.
  • P3 Health Partners' Free Cash Flow's 5-year high stood at -$6.8 million during Q3 2021, with a 5-year trough of -$57.2 million in Q4 2024.
  • Moreover, its 5-year median value for Free Cash Flow was -$21.9 million (2022), whereas its average is -$23.0 million.
  • Data for P3 Health Partners' Free Cash Flow shows a peak YoY increase of 6589.41% (in 2024) and a maximum YoY decrease of 26536.45% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows P3 Health Partners' Free Cash Flow stood at -$11.6 million in 2021, then crashed by 175.0% to -$31.9 million in 2022, then skyrocketed by 50.9% to -$15.7 million in 2023, then plummeted by 265.36% to -$57.2 million in 2024, then surged by 73.07% to -$15.4 million in 2025.
  • Its Free Cash Flow stands at -$15.4 million for Q3 2025, versus -$16.6 million for Q2 2025 and -$33.5 million for Q1 2025.